David Goodman-Meza, MD, MAS

David Goodman-Meza, MD, MAS is a Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA. His diverse research interest include the epidemiology of HIV and STIs in high-risk populations, biomedical prevention of HIV in people who use substances, and improving infectious disease-related outcomes in people who inject drugs. He is site principal investigator for HPTN094, a randomized controlled trial evaluating the efficacy of mobile clinical unit to improve health outcomes in people who inject drugs.

Contact: dgoodman@mednet.ucla.edu 

FEATURED PUBLICATIONS:

1. Goodman-Meza, D., Shoptaw, S., Hanscom, B., Smith, L. R., Andrew, P., Kuo, I., Lake, J. E., Metzger, D., Morrison, E. A. B., Cummings, M., Fogel, J. M., Richardson, P., Harris, J., Heitner, J., Stansfield, S., El-Bassel, N., & HPTN 094 Study Team (2024). Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study). Trials, 25(1), 124. https://doi.org/10.1186/s13063-023-07899-5

2. Edwards, G. G., Miyashita-Ochoa, A., Castillo, E. G., Goodman-Meza, D., Kalofonos, I., Landovitz, R. J., Leibowitz, A. A., Pulsipher, C., El Sayed, E., Shoptaw, S., Shover, C. L., Tabajonda, M., Yang, Y. S., & Harawa, N. T. (2023). Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine. AIDS and behavior, 27(1), 10–24. https://doi.org/10.1007/s10461-022-03817-z

3. Gonzalez-Nieto, P., Salimian, A., Arredondo, J., Angulo, L., García de Loera, A., Slim, S., Shoptaw, S., Cambou, M. C., Pitpitan, E. V., & Goodman-Meza, D. (2023). Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico. Harm reduction journal, 20(1), 79. https://doi.org/10.1186/s12954-023-00815-9